Judy Visit 1: A 77-year-old woman with blurry vision

Age-related Macular Degeneration: Seeing the Way Into the Future
0.75 AMA PRA Category 1 Credit(s)™
Launch Date:
August 08, 2013
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

No primary audience was provided.

Relevant Terms:

No primary audience was provided.

William F. Mieler, MD

William F. Mieler, MD
Director, Ocular Oncology
Professor and Vice-Chairman
The Department of Ophthalmology and Visual Sciences
The University of Illinois at Chicago
Center for Advanced Medicine
Chicago, IL

Dr. Mieler has a long and distinguished career as an expert in treating diseases of the macula, retina and vitreous. His primary research interests are ocular pharmacology, exploring drug delivery to the posterior segment of the eye, uptake (and potential toxicity) of topical, periocular, and systemic medications, intraocular tumors and response to therapy and ocular imaging. He also participates in numerous national clinical trials in the treatment of age-related macular degeneration, diabetic macular edema, venous occlusive diseases, and vitreoretinal interface disorders. Dr. Mieler has led the American Board of Ophthalmology (AAO) as its director, vice-chair and chair, and he has served as the president of the Macula Society, which awarded him the prestigious J. Donald Gass Medal in 2013 for his outstanding contributions to the study of macular diseases. Dr. Mieler has received the Life Achievement Honor Award from the AAO and he currently chairs the AAO Subspecialty Day programs. He has published 330 peer-reviewed articles along with 70 book chapters, and has edited or co-edited six ophthalmic textbooks. He has delivered 19 named lectures, and has served on Editorial Boards for three ophthalmic journals, and serves as a reviewer for 22 additional journals.  He also serves as the Association for Research in Vision and Ophthalmology (ARVO) as the Retina Section Trustee and President-Elect. Dr. Mieler has also served the American Board of Medical Specialties (ABMS) on a number of committees. He joined the Department in 2008. Dr. Mieler is Board Certified in Ophthalmology.

Neil M. Bressler, MD

Neil M. Bressler, MD*
Chief, Retina Division of The Wilmer Eye Institute
The James P. Gills Professor of Ophthalmology
Johns Hopkins University School of Medicine
Baltimore, MD

*(Participation by Dr. Neil Bressler in this activity does not constitute or imply endorsement by the Johns Hopkins University, the Johns Hopkins Hospital, or the Johns Hopkins Health System)

Dr. Neil M. Bressler graduated from Johns Hopkins University School of Medicine in 1982 and completed an ophthalmology residency at Harvard Medical School's Massachusetts Eye and Ear Infirmary in 1986. He joined the Wilmer Eye Institute faculty at Johns Hopkins in 1988, where he currently is Chief of the Retina Division and the inaugural James P. Gills Professor of Ophthalmology. With over 15 full-time clinical faculty, the Retina Division serves the Johns Hopkins Hospital and an additional 5 satellite clinics, dedicated to basic, translational, and clinical research in conjunction with clinical care and education revolving around the prevention and treatment of retinal diseases.
His main research interests have been collaborative efforts in clinical trials of common retinal diseases, including age-related macular degeneration and diabetic retinopathy, having chaired several NIH-sponsored and industry-sponsored multicenter randomized clinical trials and authored over 300 peer-reviewed publications. He has chaired the NIH-sponsored Diabetic Retinopathy Clinical Research Network where he currently serves as Past Network Chair, responsible for guidelines, policies, protocol development as well as implementation, and to facilitate Network operations in a way that maintains academic integrity and optimal clinical trial performance. He chairs the National Eye Institute's Data and Safety Monitoring Committee for intramural clinical trials, has chaired the FDA Ophthalmic Devices Panel, has chaired the Committee on Outside Interests (including conflicts of interest) and is chair of the Continuing Medical Education Advisory Board at the Johns Hopkins University School of Medicine.
Since July 2013, Dr. Bressler has been Editor-in-Chief of JAMA Ophthalmology, one of the leading peer-reviewed ophthalmic journals in the world. He has won numerous awards in ophthalmology, including the Macula Society's J. Donald M. Gass Medal, the Society of Heed Fellows Award, the American Society of Retina Specialists Gertrude Pyron Award, the American Academy of Ophthalmology's Secretariat Award, a Gold Fellow in ARVO, and a Senior Scientific Investigator Award from Research to Prevent Blindness. He was elected to be President of the Macula Society in 2013 and 2014, one of three major retina societies in the U.S. Outside of medicine, as a member of the Board of Trustees for the Interlochen Center for the Arts, he also shares responsibility for an entity which engages and inspires people worldwide through excellence in educational, artistic and cultural programs in the arts.

Peter K. Kaiser, MD

Peter K. Kaiser, MD
Chaney endowed Chair in Ophthalmology Research
Professor of Ophthalmology
Cleveland Clinic
Lerner College of Medicine
Vitreonretinal Department
Cole Eye Institute
Cleveland, OH

Peter K. Kaiser, M.D. graduated magna cum laude with Highest Honors from Harvard College and magna cum laude from Harvard Medical School. He completed an internal medicine internship at Massachusetts General Hospital, an ophthalmology residency at the Massachusetts Eye and Ear Infirmary, and a vitreoretinal fellowship at Bascom Palmer Eye Institute before joining the vitreoretinal department of the Cole Eye Institute at the Cleveland Clinic Foundation, Cleveland, Ohio where he is the Chaney Family Endowed Professor of Ophthalmology Research at the Cleveland Clinic Lerner College of Medicine.
As a National Eye Institute and National Institute of Health RO1-funded principle investigator, Dr. Kaiser leads a team involved in the evaluation of vascular biology in age-related macular degeneration (AMD) and diabetic retinopathy (DR). In addition, Dr Kaiser is actively involved in clinical research having served as Study Chairman for 5 major, multi-center, international clinical trials, and principal investigator in over 50 trials evaluating new treatments for AMD, DR, and other retinal disorders. He is the founder and director of the Digital Optical Coherence Tomography Reading Center (DOCTR), which is the OCT reading center for over 700 international sites and 45 multi-center, clinical trials. Dr. Kaiser has been honored to receive the Lew R. Wasserman Award from the Research to Prevent Blindness for his research. Complementing his research endeavors, Dr. Kaiser serves on numerous scientific advisory boards and addresses his research interests as an invited speaker at national and international conferences. He is a major contributor to the medical literature having authored 7 textbooks, 25 book chapters, and more than 200 peer-reviewed manuscripts. He is Editor-in-Chief of Retinal Physician, Associate Editor of International Ophthalmology Clinics, and serves on the editorial boards of American Journal of Ophthalmology, Retina, Retina Today, and Ocular Surgery News. Dr. Kaiser has been recognized by the American Academy of Ophthalmology and American Society of Retina Specialists with Achievement and Senior Achievement Awards, and has been listed as one of the "Best Doctors in America" since 2002. He is the team ophthalmologist for the Cleveland Browns (National Football League) and Cleveland Cavaliers (National Basketball Association).
1. Identify risk factors associated with AMD in order to increase understanding the burden of the disease.
2. Individualize treatment plans for patients with AMD in order to improve long-term management.
3. Compare and contrast the current and potential future treatment of patients with AMD.